How much revenue does Paxman AB (publ) make?

Paxman AB (publ) reported 313.35 million SEK in revenue for fiscal year 2025, up 23.8% from 253.01 million SEK in fiscal year 2024.

Where does Paxman AB (publ) make most of its revenue?

North America: 59% of revenue by region in fiscal year 2025, followed by Europe (16%).

What companies are similar to Paxman AB (publ)?

Listed companies of a similar size in the same industry (targeted healthcare equipment) include Elekta AB (publ) (EKTA-B.ST), Vitrolife AB (publ) (VITR.ST), Dynavox Group AB (publ) (DYVOX.ST), Episurf Medical AB (publ) (EPIS-B.ST).

Paxman AB (publ) (PAX.ST) Stock

About Paxman AB (publ)

Paxman AB (publ), together with its subsidiaries, provides cryotherapy solutions in the United Kingdom, Europe, North and South America, Oceania, and Asia. The company offers Paxman scalp cooling system, a mechanized form of scalp cooling for the prevention of chemotherapy-induced alopecia. It also engages in the development of a medical cryocompression device for the prevention of chemotherapy-in...

At a glance

Paxman AB (publ) reported revenue of 313.35 million SEK for fiscal year 2025, up 23.8% from fiscal year 2024, and net income of -16.72 million SEK. North America was its largest region in fiscal year 2025, with 59% of revenue.

Figures from company filings; latest fiscal year ended December 31, 2025.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.